FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Trimethobenzamide Hydrochloride Capsules
Status: Currently in Shortage
»Date first posted: 02/16/2021
»Therapeutic Categories: Gastroenterology

Expand all

Lupin (New 02/16/2021)

Company Contact Information:
866-587-4617

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
300 mg, bottle of 30 (NDC 43386-660-03) Currently unavailable. Estimated shortage duration: TBD Shortage of an active ingredient.
300 mg, bottle of 100 (NDC 43386-660-24) Currently unavailable. Estimated shortage duration: TBD Shortage of an active ingredient.
300 mg, bottle of 500 (NDC 43386-660-26) Currently unavailable. Estimated shortage duration: TBD Shortage of an active ingredient.

Pfizer Pharmaceuticals (Reverified 04/23/2021)

Company Contact Information:
800-533-4535

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
300 mg, bottle of 100 (NDC 61570-079-01) Drop ship orders only

Link to Discontinuance

Discontinuation of the manufacture of the drug.

Sun Pharmaceutical Industries Inc. (New 02/16/2021)

Company Contact Information:
800-810-4555

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
300 mg, bottle of 100 (NDC 53489-376-01) Unavailable Shortage of an active ingredient.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English